Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
invitae
2
×
life sciences
national blog main
san francisco blog main
san francisco top stories
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clinical trials
clostridium difficile
community-acquired bacterial pneumonia
dana hilt
daprodustat
david chacko
david marek
deals
detroit blog main
detroit top stories
duchenne muscular dystrophy
eli lilly
endo pharmaceuticals
What
bio
ability
acquire
array
august
babies
biotech
business
busy
cost
days
deal
decisions
devices
drugs
expand
fda
genetic
invitae
legacy
low
maker
medical
news
nods
offers
opioid
past
prenatal
reached
regulatory
roundup
sarepta’s
screen
seven
shkreli’s
singular
slow
stumble
suits
Language
unset
Current search:
invitae
×
photo
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business